From: Cost-utility analysis of palliative care in patients with advanced cancer: a retrospective study
Variable | n | Cost | F | P | |
---|---|---|---|---|---|
Sex | Male | 2482 | 11,589.4 ± 10,172.5 | 3.73 | 0.047 |
Female | 1641 | 12,217.9 ± 11,421.7 | |||
Age | ≤ 40 | 522 | 8728.4 ± 9090.6 | 17.98 | 0.000 |
41—50 | 682 | 10,431.2 ± 9206.7 | |||
51—60 | 953 | 11,425 ± 9450.8 | |||
61—70 | 1131 | 12,038 ± 10,217.4 | |||
71—80 | 609 | 14,809.4 ± 13,210.2 | |||
> 80 | 226 | 16,030.9 ± 14,200.3 | |||
LOS | ≤ 3 | 281 | 3005.2 ± 1510.4 | 401.14 | 0.000 |
4–7 | 1101 | 5563.2 ± 2782.8 | |||
8–14 | 1503 | 9702.6 ± 4293.4 | |||
15–30 | 998 | 18,013.8 ± 8353.2 | |||
> 30 | 240 | 38,711.3 ± 18,453.2 | |||
Tumor site | Digestive | 1812 | 12,207.8 ± 11,079.7 | 10.03 | 0.000 |
Breast | 866 | 12,838.3 ± 10,859.3 | |||
Head and neck | 557 | 9650.6 ± 7485.7 | |||
Gynecological | 212 | 14,372.7 ± 12,284.3 | |||
Others | 182 | 9443.8 ± 7609.3 | |||
Genitourinary | 131 | 15,326.6 ± 13,752.5 | |||
Central nervous | 94 | 12,439.2 ± 11,850.7 | |||
Eye | 85 | 2231.8 ± 1419.4 | |||
Musculoskeletal | 75 | 12,321.9 ± 12,359.6 | |||
Lymphatic | 48 | 10,396.2 ± 8864.6 | |||
Abdominal | 45 | 13,415.1 ± 12,672.5 | |||
skin | 16 | 13,471.1 ± 17,477.6 |